MA40818B2 - Administration améliorée de particules virales au striatum et au cortex - Google Patents

Administration améliorée de particules virales au striatum et au cortex

Info

Publication number
MA40818B2
MA40818B2 MA40818A MA40818A MA40818B2 MA 40818 B2 MA40818 B2 MA 40818B2 MA 40818 A MA40818 A MA 40818A MA 40818 A MA40818 A MA 40818A MA 40818 B2 MA40818 B2 MA 40818B2
Authority
MA
Morocco
Prior art keywords
striatum
cortex
viral particles
improved delivery
mammal
Prior art date
Application number
MA40818A
Other languages
English (en)
Other versions
MA40818A1 (fr
Inventor
Lamya Shihabuddin
Lisa Stanek
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Priority claimed from PCT/US2016/017210 external-priority patent/WO2016130591A2/fr
Publication of MA40818A1 publication Critical patent/MA40818A1/fr
Publication of MA40818B2 publication Critical patent/MA40818B2/fr

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne de nouveaux procédés d'administration de particules virales adéno-associées recombinées (raav) au système nerveux central d'un mammifère (p. Ex., l'homme). Selon certains aspects, les procédés impliquent l'administration des particules raav contenant un acide nucléique hétérologue au striatum et l'induction de l'expression de l'acide nucléique hétérologue dans au moins le cortex cérébral et le striatum du mammifère.
MA40818A 2015-02-10 2016-02-09 Administration améliorée de particules virales au striatum et au cortex MA40818B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562114544P 2015-02-10 2015-02-10
PCT/US2016/017210 WO2016130591A2 (fr) 2015-02-10 2016-02-09 Administration améliorée de particules virales au striatum et au cortex

Publications (2)

Publication Number Publication Date
MA40818A1 MA40818A1 (fr) 2018-01-31
MA40818B2 true MA40818B2 (fr) 2022-04-29

Family

ID=61730514

Family Applications (1)

Application Number Title Priority Date Filing Date
MA40818A MA40818B2 (fr) 2015-02-10 2016-02-09 Administration améliorée de particules virales au striatum et au cortex

Country Status (2)

Country Link
HR (1) HRP20220042T1 (fr)
MA (1) MA40818B2 (fr)

Also Published As

Publication number Publication date
MA40818A1 (fr) 2018-01-31
HRP20220042T1 (hr) 2022-04-01

Similar Documents

Publication Publication Date Title
EP4219728A3 (fr) Administration améliorée de particules virales au striatum et au cortex
MA39390A1 (fr) Thérapie génique pour le traitement de la rétinite pigmentaire
CY1124905T1 (el) Ιοσωματιδια αδενο-συσχετιζομενου ιου με καψιδιο παραλλαγματος και μεθοδοι χρησης εξ' αυτων
MX2020003176A (es) Variantes de capsides de virus adenoasociados y metodos de uso de estas.
MX2023009627A (es) Capsides variantes de virus adenoasociados y metodos de uso de las mismas.
Bassi et al. CD8+ T cells complement antibodies in protecting against yellow fever virus
PH12018500594A1 (en) Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same
EA202090738A1 (ru) Способ безопасного индуцирования иммунитета против rsv
Jiang et al. Type I IFN signaling facilitates the development of IL‐10‐producing effector CD8+ T cells during murine influenza virus infection
JP6263559B2 (ja) 従来型樹状細胞によるｉｆｎ‐ラムダの産生及びその使用
Abboud et al. Transcription factor Bcl11b controls effector and memory CD8 T cell fate decision and function during poxvirus infection
Slowikowski et al. A central role for CCR2 in monocyte recruitment and blood–brain barrier disruption during Usutu virus encephalitis
EA201490758A1 (ru) Вакцины против вируса человеческой папилломы и способы их применения
Manangeeswaran et al. CpG oligonucleotides protect mice from alphavirus encephalitis: role of NK cells, interferons, and TNF
MA40818B2 (fr) Administration améliorée de particules virales au striatum et au cortex
Khandelwal et al. Stem cell therapy: a novel approach against emerging and re-emerging viral infections with special reference to SARS-CoV-2
Choi et al. Exacerbation of Japanese encephalitis by CD11chi dendritic cell ablation is associated with an imbalance in regulatory Foxp3+ and IL-17+ CD4+ Th17 cells and in Ly-6Chi and Ly-6Clo monocytes
DE60024259D1 (de) Trennung eines humanen retrovirus
de Oliveira Apolipoprotein (a) inhibits hepatitis C virus through interaction with infectious particles
Lopez Towards harnessing inflammation during chikungunya virus infection
WO2018056528A3 (fr) Vaccin contre la grippe b
JP2025522278A (ja) ヒトがんに対する腫瘍溶解性ウイルスプラットフォームとしての操作されたジュロナウイルス（ｊｕｒｖ）の使用
Tsai et al. Glycobiological study of acutobin (defibrase) and its HEK-293T recombinant
Pelikh et al. DISEASES OF THE UPPER RESPIRATORY TRACT AND EAR IN CHILDREN IN LARGE INDUSTRIAL CENTERS
MY186651A (en) Adeno-associated virus variant capsids and methods of use thereof